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In the original publication of the article, the Fig. 4c and d were published erroneously. The revised Fig. [4](#Fig4){ref-type="fig"} is given in this erratum.Fig. 4Expression of a phosphomimetic, cell-cycle inert p27 mutant conveys resistance to PF1502. **a** Western analysis shows GFP-p27CK-T157DT198D (p27CK-DD) expression in 231 and 1833 (control represents empty-vector transfection). **b** Migration in 231 +/− PF1502 with or without p27CK-T157DT198D, mean +/− SEM (T-test of 231p27CK-DD (*top*) and 231 (*bottom*) with or without drug \**p* = 0.01,^‡^ *p* = 0.11; 231CK-DD vs. 231 control *p* \< 0.0001). **c**--**d**, Matrigel invasion of 231 (**c**) and 1833 cells (**d**) transduced with p27CK-DD, with and without 48 h PF1502 250 nM and graphed +/− SEM. (T-tests as indicated: \**p* = 0.003, ^‡^ *p* = 0.068 (*left*); \**p* = 0.0002, ^‡^ *p* = 0.064 (*right*)) (**c**, **d**)

The online version of the original article can be found under doi:10.1007/s10549-012-2389-6.
